Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Expected to Rise, Citigroup Analyst Says

Chronological Source Flow
Back

AI Fusion Summary

Analysts from B. Riley Financial, Citigroup, and Stephens have raised their price targets for L.B. Foster, Arcturus Therapeutics, and CrowdStrike, respectively. While B. Riley and Citigroup maintain "neutral" ratings, Stephens has an "overweight" rating on CrowdStrike, suggesting a positive outlook on these stocks.
06/03 09:10 defenseworld.net
3 Πηγές
06/03 10:48 defenseworld.net
06/03 10:56 defenseworld.net
Comments
Loading...
0